Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.840
+0.050 (2.79%)
Jun 25, 2025, 10:40 AM - Market open
Milestone Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 45.09 | 25.31 | 13.76 | 7.64 | 114.14 | 72.31 | Upgrade
|
| Short-Term Investments | 10.87 | 44.38 | 52.24 | 56.95 | - | 70 | Upgrade
|
| Cash & Short-Term Investments | 55.96 | 69.7 | 66 | 64.59 | 114.14 | 142.31 | Upgrade
|
| Cash Growth | -37.46% | 5.59% | 2.20% | -43.42% | -19.79% | 18.77% | Upgrade
|
| Other Receivables | 1.49 | 1.72 | 1.45 | 1.21 | 0.48 | 0.95 | Upgrade
|
| Receivables | 1.49 | 1.72 | 1.45 | 1.21 | 0.48 | 0.95 | Upgrade
|
| Prepaid Expenses | 2.36 | 1.84 | 3.18 | 6.01 | 4.3 | 5.43 | Upgrade
|
| Other Current Assets | 0.67 | 0.67 | 2.4 | - | - | - | Upgrade
|
| Total Current Assets | 60.48 | 73.93 | 73.03 | 71.8 | 118.92 | 148.69 | Upgrade
|
| Property, Plant & Equipment | 1.41 | 1.57 | 2.19 | 2.68 | 0.93 | 1.29 | Upgrade
|
| Total Assets | 61.89 | 75.5 | 75.23 | 74.48 | 119.85 | 149.97 | Upgrade
|
| Accounts Payable | 2.38 | 1.93 | 3.98 | 2.26 | 4.38 | 4.64 | Upgrade
|
| Accrued Expenses | 10.04 | 5.62 | 2.7 | 3.38 | 2.17 | 1.27 | Upgrade
|
| Current Portion of Leases | 0.54 | 0.57 | 0.55 | 0.5 | 0.22 | 0.25 | Upgrade
|
| Total Current Liabilities | 12.96 | 8.13 | 7.23 | 6.14 | 6.78 | 6.16 | Upgrade
|
| Long-Term Debt | 54.29 | 53.35 | 49.77 | - | - | - | Upgrade
|
| Long-Term Leases | 0.76 | 0.87 | 1.46 | 2 | 0.47 | 0.7 | Upgrade
|
| Total Liabilities | 68.01 | 62.35 | 58.46 | 8.14 | 7.25 | 6.86 | Upgrade
|
| Common Stock | 288.19 | 288.05 | 260.5 | 273.9 | 251.9 | 251.68 | Upgrade
|
| Additional Paid-In Capital | 40.92 | 39.57 | 33.83 | 24.44 | 15.71 | 8.53 | Upgrade
|
| Retained Earnings | -388.31 | -367.55 | -326.03 | -266.34 | -207.95 | -163.47 | Upgrade
|
| Comprehensive Income & Other | 53.08 | 53.08 | 48.46 | 34.35 | 52.94 | 46.37 | Upgrade
|
| Total Common Equity | -6.12 | 13.15 | 16.77 | 66.35 | 112.6 | 143.12 | Upgrade
|
| Shareholders' Equity | -6.12 | 13.15 | 16.77 | 66.35 | 112.6 | 143.12 | Upgrade
|
| Total Liabilities & Equity | 61.89 | 75.5 | 75.23 | 74.48 | 119.85 | 149.97 | Upgrade
|
| Total Debt | 55.59 | 54.8 | 51.78 | 2.49 | 0.7 | 0.94 | Upgrade
|
| Net Cash (Debt) | 0.37 | 14.9 | 14.23 | 62.09 | 113.44 | 141.37 | Upgrade
|
| Net Cash Growth | -99.00% | 4.71% | -77.09% | -45.26% | -19.75% | 18.50% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.24 | 0.33 | 1.46 | 2.71 | 4.82 | Upgrade
|
| Filing Date Shares Outstanding | 66.37 | 66.26 | 43.06 | 42.8 | 42.23 | 41.25 | Upgrade
|
| Total Common Shares Outstanding | 66.37 | 66.26 | 43.06 | 42.8 | 42.23 | 41.25 | Upgrade
|
| Working Capital | 47.51 | 65.8 | 65.81 | 65.66 | 112.15 | 142.53 | Upgrade
|
| Book Value Per Share | -0.09 | 0.20 | 0.39 | 1.55 | 2.67 | 3.47 | Upgrade
|
| Tangible Book Value | -6.12 | 13.15 | 16.77 | 66.35 | 112.6 | 143.12 | Upgrade
|
| Tangible Book Value Per Share | -0.09 | 0.20 | 0.39 | 1.55 | 2.67 | 3.47 | Upgrade
|
| Machinery | - | 0.4 | 0.38 | 0.28 | 0.43 | 0.43 | Upgrade
|
| Leasehold Improvements | - | 0.09 | 0.09 | 0.1 | 0.03 | 0.03 | Upgrade
|
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.